[HTML][HTML] The role of flavonoids as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: a review
RA Syahputra, U Harahap, A Dalimunthe, MP Nasution… - Molecules, 2022 - mdpi.com
Doxorubicin is a widely used and promising anticancer drug; however, a severe dose-
dependent cardiotoxicity hampers its therapeutic value. Doxorubicin may cause acute and …
dependent cardiotoxicity hampers its therapeutic value. Doxorubicin may cause acute and …
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
RA Lewis, C Durrington, R Condliffe… - European Respiratory …, 2020 - Eur Respiratory Soc
Despite the advent of new therapies and improved outcomes in patients with pulmonary
arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis …
arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis …
Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction
Background: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type
natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict …
natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict …
Heart failure biomarkers BNP and NT-proBNP detection using optical labels
OA Goryacheva, TD Ponomaryova, DD Drozd… - TrAC Trends in …, 2022 - Elsevier
In the context of the high risk of heart failure (HF), rapid assessment of biomarker levels in
patients appears to be a quick and accurate approach to diagnosis and timely treatment …
patients appears to be a quick and accurate approach to diagnosis and timely treatment …
Cardiac biomarkers in pediatrics: an undervalued resource
Background The clinical use of common cardiac biomarkers, such as brain natriuretic
peptides and troponins, has traditionally been limited to adult populations in the assessment …
peptides and troponins, has traditionally been limited to adult populations in the assessment …
[HTML][HTML] Cardiac troponin I reveals diagnostic and prognostic superiority to aminoterminal pro-B-type natriuretic peptide in sepsis and septic shock
J Forner, T Schupp, K Weidner, J Rusnak… - Journal of Clinical …, 2022 - mdpi.com
Data regarding the prognostic value of cardiac biomarkers in patients suffering from sepsis
or septic shock is scarce. Studies investigating the prognostic role of cardiac biomarkers in …
or septic shock is scarce. Studies investigating the prognostic role of cardiac biomarkers in …
[HTML][HTML] The conundrum of volume status assessment: revisiting current and future tools available for physicians at the bedside
MG Elhassan, PW Chao, A Curiel - Cureus, 2021 - ncbi.nlm.nih.gov
Assessment of patients' volume status at the bedside is a very important clinical skill that
physicians need in many clinical scenarios. Hypovolemia with hypotension and tissue under …
physicians need in many clinical scenarios. Hypovolemia with hypotension and tissue under …
[HTML][HTML] Clinical significance of the long non‑coding RNA NEAT1/miR‑129‑5p axis in the diagnosis and prognosis for patients with chronic heart failure
H Zhang, N Zhang, W Jiang… - Experimental and …, 2021 - spandidos-publications.com
Chronic heart failure (CHF) is the leading cause of death worldwide. The regulatory
interactions of long non‑coding RNA (lncRNAs) and microRNAs (miRs) have important roles …
interactions of long non‑coding RNA (lncRNAs) and microRNAs (miRs) have important roles …
Effect of n-3 PUFA on left ventricular remodelling in chronic heart failure: a systematic review and meta-analysis
J Liu, Q Meng, L Zheng, P Yu, H Hu… - British Journal of …, 2023 - cambridge.org
Accumulating evidence suggests that supplementation of n-3 PUFA was associated with
reduction in risk of major cardiovascular events. This meta-analysis was to systematically …
reduction in risk of major cardiovascular events. This meta-analysis was to systematically …
Biomarkers in heart failure: relevance in the clinical practice
Early detection and risk stratification of patients with heart failure (HF) are crucial to improve
outcomes. Given the complexity of the pathophysiological processes of HF and the …
outcomes. Given the complexity of the pathophysiological processes of HF and the …